Unlock instant, AI-driven research and patent intelligence for your innovation.

Polypeptide conjugate for targeting tumor cells as well as preparation method and application of polypeptide conjugate

A technology of polypeptide coupling and tumor cells, which is applied in the biological field and can solve difficult problems such as tumor antigens

Pending Publication Date: 2022-03-15
北京双赢科创生物科技有限公司
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Tumor cells have strong heterogeneity and proliferative ability, and their high mutation rate during growth makes it difficult for us to find mutations in multiple tumors or between different patients of the same tumor type during tumor treatment. Stably expressed specific tumor antigen

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polypeptide conjugate for targeting tumor cells as well as preparation method and application of polypeptide conjugate
  • Polypeptide conjugate for targeting tumor cells as well as preparation method and application of polypeptide conjugate
  • Polypeptide conjugate for targeting tumor cells as well as preparation method and application of polypeptide conjugate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0049] Example 1, Construction of the polypeptide conjugate pHLIP-CD19

[0050] 1. Linking CD19 with coupling agent sulfo-SMCC

[0051] Dissolve 4800nmol sulfo-SMCC (Thermo Scientific, USA) in 300μL PBS solution and 10nmol CD19 (Sino Biological Inc, China) in 200μL PBS solution, mix the sulfo-SMCC solution and CD19 solution to 1.5mL The Eppendorf centrifuge tube was gently shaken at room temperature for 2 hours. During the whole process, the pH of the mixed solution was controlled to be 7.4 to obtain a CD19 polypeptide conjugate solution. Then, the CD19 polypeptide conjugate solution was purified with a column of NAP-5 (GE Healthcare, UK) pre-equilibrated with PBS buffer to obtain a solution containing the purified CD19 polypeptide conjugate, such as figure 1 Shown, a schematic diagram of the connection of the pHLIP-CD19 polypeptide conjugate.

[0052] 2. Linking CD19 polypeptide conjugates with the insertion peptide pHLIP targeting tumor cells

[0053] Such as image 3 Sh...

Embodiment 2

[0055] Example 2, Cell Transformation of pHLIP-CD19 Polypeptide Conjugates

[0056] 1. Transform the recombinant pHLIP-CD19 polypeptide conjugate to the cell surface.

[0057] OCI-LY8 is a human diffuse large B lymphoma cell line, which itself expresses CD19 molecules. It is used as a positive control group for killing experiments. It is cultured in RPMI-1640 cell culture medium. MG63 cells are osteosarcoma cells, cultured with DMEM medium , add 10% FBS (WISENT, Canada), culture at 37°C, 5% CO 2 in the cell culture incubator.

[0058] The pHLIP-CD19 polypeptide conjugate and MG63 cells were respectively co-cultured and induced for 2 hours under the environment of pH=6.8, during which the pH value of the solution was maintained. Such as figure 2 Shown is a schematic diagram of the process in which the pHLIP-CD19 polypeptide conjugate of this example undergoes self-curling and is inserted into the surface of the tumor cell membrane.

[0059] 2. Flow cytometry for peptide in...

Embodiment 3

[0061] Embodiment 3, the detection of cytotoxicity in vitro

[0062] 1. Construction of CAR T cells

[0063] T cells were isolated from human blood using the magnetic bead method. After being activated by the CD3 / CD28 complex, the packaged lentivirus was used to infect according to the virus titer, and the expression level was detected by flow cytometry for 48 hours.

[0064] Add 15ml of lymphocyte separation medium to a 50ml centrifuge tube, slowly add 30ml of whole blood into the 50ml centrifuge tube filled with lymphocyte separation medium, and centrifuge at 800g for 25min (centrifugation speed increases slowly, up to 1 down to 0). After centrifugation, carefully draw the mononuclear cell layer cells into a new 50ml centrifuge tube, add PBS to 50ml, gently pipette evenly, and centrifuge at 500g for 10min.

[0065] Resuspend the cell pellet with 50ml PBS and count the cells. Centrifuge at 300g for 10min. Cell pellets were resuspended in buffer (x-vivo basal medium + 10% F...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a polypeptide conjugate for targeting tumor cells as well as a preparation method and application of the polypeptide conjugate. The polypeptide conjugate comprises an insertion peptide targeting tumor cells, a coupling agent and CD19 polypeptide, wherein the insertion peptide is connected with the CD19 polypeptide through the coupling agent; the insertion peptide is selected from the following (a1) or (a2): (a1) a polypeptide with an amino acid sequence as shown in SEQ ID NO.1; and (a2) polypeptide which is obtained by substituting and / or deleting and / or adding one or more amino acid residues on the amino acid sequence as shown in SEQ ID NO.1, has a tumor cell targeting function and is derived from (a1). According to the invention, the tumor hypoxia and acidification characteristics which originally influence the development and treatment effect of tumors are utilized, the tumor hypoxia and acidification characteristics become targeting conditions for treatment, target molecules can be specifically inserted into cells of a tumor microenvironment, a specific mark is provided for tumors, a target spot is provided for targeted killing and treatment, and the tumor microenvironment is protected. Therefore, immune cells are attracted to attack and kill in a targeted manner.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to a polypeptide conjugate for targeting tumor cells and its preparation method and application. Background technique [0002] The tumor microenvironment is composed of tumor cells, a variety of stromal cells, and a series of cytokines and chemokines. Among them, stromal cells include fibroblasts, tumor-infiltrating immune cells, endothelial cells, immature cells derived from bone marrow, etc.; cytokines such as TNF, VEGF, IL-1, etc.; chemokines such as CXCL12, CCL27, CCL21, etc. Cytokines and chemokines can be secreted by tumor cells, and can also be produced by stromal cells and the above-mentioned infiltrating immune cells. These cells and active media together form a stable tumor immune microenvironment, which protects tumor tissues from the body's immune surveillance and promotes tumor progression. Tumor cells have strong heterogeneity and proliferative ability, and their high mu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K19/00C07K1/10C12N5/09A61K39/00A61K47/64A61P35/00A61P35/02
CPCC07K14/70503C12N5/0693A61K39/001112A61K47/64A61P35/00A61P35/02C07K2319/33
Inventor 秦志海陶宁李建茹陈波李香群
Owner 北京双赢科创生物科技有限公司